Items where Author is "Paolini, S"

Journal article

RAGAINI, S., WAGNER, S., MARCONI, G., PARISI, S., SARTOR, C., NANNI, J., CRISTIANO, G., TALAMI, A., OLIVI, M., OCADLIKOVA, D., CICIARELLO, M., CORRADI, G., OTTAVIANI, E., PAPAYANNIDIS, C., PAOLINI, S., VADAKEKOLATHU, J., CAVO, M., RUTELLA, S. and CURTI, A., 2021. An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia. Blood Advances. ISSN 2473-9529

KAUFF, M., BENEDA, M., PAOLINI, S., BILEWICZ, M., KOTZUR, P., O'DONNELL, A.W., STEVENSON, C., WAGNER, U. and CHRIST, O., 2020. How do we get people into contact? Predictors of intergroup contact and drivers of contact seeking. Journal of Social Issues. ISSN 0022-4537

UY, G.L., ALDOSS, I., FOSTER, M.C., SAYRE, P.H., WIEDUWILT, M.J., ADVANI, A.S., GODWIN, J.E., ARELLANO, M.L., SWEET, K., EMADI, A., RAVANDI, F., ERBA, H.P., BYRNE, M., MICHAELIS, L.C., TOPP, M.S., VEY, N., CICERI, F., CARRABBA, M.G., PAOLINI, S., HULS, G., JONGEN-LAVRENCIC, M., WERMKE, M., CHEVALLIER, P., GYAN, E., RÉCHER, C., STIFF, P., PETTIT, K., LÖWENBERG, B., CHURCH, S., ANDERSON, E.K., VADAKEKOLATHU, J., SANTAGUIDA, M.T., RETTIG, M.P., MUTH, J., CURTIS, T., FEHR, E., GUO, K., ZHAO, J., BAKKACHA, O., JACOBS, K., TRAN, K., KAMINKER, P., KOSTOVA, M., BONVINI, E., WALTER, R.B., DAVIDSON-MONCADA, J.K., RUTELLA, S. and DIPERSIO, J.F., 2020. Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. Blood. ISSN 0006-4971

RAGAINI, S., WAGNER, S., MARCONI, G., PARISI, S., SARTOR, C., NANNI, J., CRISTIANO, G., TALAMI, A., OLIVI, M., OCADLIKOVA, D., CICIARELLO, M., CORRADI, G., OTTAVIANI, E., PAPAYANNIDIS, C., PAOLINI, S., VADAKEKOLATHU NARAYANAN, J., CAVO, M., RUTELLA, S. and CURTI, A., 2019. An IDO1-related 3-gene signature predicts overall survival in intermediate-risk acute myeloid leukemia. Blood, 134 (Supp1): 5193. ISSN 0006-4971

UY, G.L., RETTIG, M.P., VEY, N., GODWIN, J., FOSTER, M.C., RIZZIERI, D.A., ARELLANO, M.L., TOPP, M.S., HULS, G., JONGEN-LAVRENCIC, M., MARTINELLI, G., PAOLINI, S., CICERI, F., CARRABBA, M.G., SWEET, K.L., RAVANDI, F., CHURCH, S.E., VADAKEKOLATHU, J., RUTELLA, S., SUN, J., YANG, K., BAUGHMAN, J., CURTIS, T., TIMMENY, E., CALI, K., TRAN, K., MUTH, J., LA MOTTE-MOHS, R., POIROT, C., PALLIS, A., CESANO, A., BONVINI, E., WIGGINGTON, J., LOWENBERG, B., DAVIDSON-MONCADA, J.K. and DIPERSIO, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971